Point72 Hong Kong Ltd - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$14,000
+16.7%
2,870
+195.6%
0.00%
-100.0%
Q4 2020$12,000
-14.3%
971
-31.4%
0.00%0.0%
Q3 2020$14,000
+27.3%
1,416
+26.7%
0.00%0.0%
Q2 2020$11,0001,118
+4558.3%
0.00%
Q2 2019$0
-100.0%
24
-98.4%
0.00%
-100.0%
Q1 2019$18,000
+800.0%
1,479
+1197.4%
0.01%
+600.0%
Q3 2017$2,000
+100.0%
114
+14.0%
0.00%0.0%
Q3 2016$1,0001000.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 1,050,124$10,312,0003.31%
Alambic Investment Management, L.P. 19,934$196,0002.15%
INGALLS & SNYDER LLC 1,363,603$13,391,0000.92%
ACUTA CAPITAL PARTNERS, LLC 300,000$2,946,0000.80%
RA Capital Management 1,858,474$18,250,0000.33%
Perceptive Advisors 2,150,641$21,119,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 310,000$3,044,0000.30%
Eversept Partners, LP 103,829$1,019,6010.23%
Opaleye Management Inc. 100,000$982,0000.19%
GSA CAPITAL PARTNERS LLP 58,095$570,0000.10%
View complete list of CONCERT PHARMACEUTICALS INC shareholders